Rhythm Pharmaceuticals, Inc.
RYTM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6,498 | $4,024 | $3,340 | $3,448 |
| - Cash | $52 | $136 | $106 | $89 |
| + Debt | $151 | $4 | $4 | $4 |
| Enterprise Value | $6,597 | $3,893 | $3,238 | $3,363 |
| Revenue | $51 | $49 | $33 | $42 |
| % Growth | 5.8% | 48.3% | -21.8% | – |
| Gross Profit | $46 | $43 | $29 | $38 |
| % Margin | 89.3% | 88.6% | 88.8% | 90.9% |
| EBITDA | -$48 | -$40 | -$44 | -$38 |
| % Margin | -93.1% | -82.7% | -133.4% | -89.8% |
| Net Income | -$53 | -$47 | -$49 | -$43 |
| % Margin | -103.1% | -96.1% | -151.4% | -103.5% |
| EPS Diluted | -0.82 | -0.75 | -0.81 | -0.72 |
| % Growth | -9.3% | 7.4% | -12.5% | – |
| Operating Cash Flow | -$27 | -$23 | -$40 | -$19 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$27 | -$23 | -$40 | -$19 |